New research that used blood markers to measure linoleic acid levels and their relation to cardiometabolic risk adds evidence ...

Weight loss injections have become incredibly popular in the last year or so. In fact, these medications are so widely used ...

Among patients with pulmonary arterial hypertension treated with selexipag, the 10-year survival rate was 60%, according to ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...

Maximum walking distance at 52 weeks was significantly improved with semaglutide. 2. There were fewer treatment-related serious adverse events in the semaglutide group compared to placebo. Evidence Ra ...

A study in weight loss drugs where one third of participants were given a placebo turned out to have some impressive results.

Novo Nordisk's early lead in weight-loss drugs fades as Eli Lilly surges ahead with more effective therapies and faster ...

Sardines contain omega-3s, calcium, vitamin D, and other heart-healthy nutrients. Learn the potential benefits of eating ...

Among patients who experienced an early cardiovascular event, those treated with semaglutide had approximately 40% fewer ...

An international study reveals that the drug can reverse liver damage in patients. An international study led by researchers ...

GLP-1 drugs like Ozempic show widespread promise beyond weight loss/diabetes, but cost and supply limit broader adoption.